1."Yuan Peif, Jingfeng Fuf, Yunkai Shif, Mengmeng Zhang, Guanghao Luo, Xiaomin Luo, Ning Song, Tian Mi, Yaxi Yang, Jia Li, * Yubo Zhou, * Bing Zhou*. Discovery of a Potent and Selective Degrader for USP7. Angew. Chem. Int. Ed. 2022, 61, e202204395.
2.Xiangbo Yang+, Huimin Lu+, Hang Xie+, Binbin Zhang, Tianqing Nie, Chen Fan, Tao Yang, Yechun Xu, Haixia Su,* Wei Tang,* and Bing Zhou*. Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis. Angew. Chem. Int. Ed. 2022, 61, e202114922.
3.Shijie Fan#, Liyan Yue#, Wei Wan#, Yuanyuan Zhang#, Bidong Zhang#, Chinatsu Otomo, Quanfu Li, Tingting Lin, Junchi Hu, Pan Xu, Mingrui Zhu, Hongru Tao, Zhifeng Chen, Lianchun Li, Hong Ding, Zhiyi Yao, Junyan Lu, Yi Wen, Naixia Zhang, Minjia Tan, Kaixian Chen, Yuli Xie, Takanori Otomo, Bing Zhou*, Hualiang Jiang*, Yongjun Dang*, and Cheng Luo*. Inhibition of autophagy by a small molecule through covalent modification of LC3. Angew. Chem. Int. Ed. 2021, 60 (50), 26105-26114.
4.Tian Lu#, Yong Li#, Wenchao Lu#, T.W.G.M. Spitters#, Xueyu Fang, Jun Wang, Simian Cai, Jing Gao, Yanting Zhou, Zhe Duan, Huan Xion, Liping Liu, Qi Li, Hualiang Jiang, Kaixian Chen, Hu Zhou, Hua Lin, Huijin Feng, Bing Zhou*, Christopher L. Antos*, Cheng Luo*. Acta Pharm. Sin. B, 2021, 11 (10), 3206-3219.
5.Liping Liao#, Wenzhen Dang#, Tingting Lin#, Jinghua Yu, Tonghai Liu, Wen Li, Senhao Xiao, Lei Feng, Jing Huang, Rong Fu, Jiacheng Li, Liping Liu, Mingchen Wang, Hongru Tao, Hualiang Jiang, Kaixian Chen Xingxing Diao, Bing Zhou*, Xiaoyan Shen*, Cheng Luo* A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1b and IL-6. Acta Pharm. Sin. B, 2022 https://doi.org/10.1016/j.apsb.2022.05.012.
6.Chao Chen#, Shi Chen#, Yaxi Yang, Bing Zhou.* Rh(III)-catalyzed tandem annulative redox-neutral arylation/amidation of aromatic tethered alkenes. Chemical Science, 2020, 11, 44, 12124-12129.
7.Yunxiang Wu, Zhaoqiang Chen, Yaxi Yang, Weiliang Zhu,* Bing Zhou.* Rh(III)-Catalyzed Redox-Neutral Unsymmetrical C-H Alkylation and Amidation Reactions of N-Phenoxyacetamides. J. Am. Chem. Soc., 2018, 140, 42.
8.Yunxiang Wu, Bing Zhou*. Ruthenium-Catalyzed Direct Hydroxymethylation of Aryl C–H Bonds. ACS Catal., 2017, 7, 2213.
9.Yaxi Yang, Xuan Wang, Yuanchao Li, and Bing Zhou* A [4+1] Cyclative Capture Approach to 3H-Indole-N-oxides at Room Temperature by Rhodium(III)-Catalyzed C-H Activation. Angew. Chem. Int. Ed. 2015, 54, 15400-15404.
10.Bing Zhou,* Zhaoqiang Chen, Yaxi Yang,* Wen Ai, Huanyu Tang, Yunxiang Wu, Weiliang Zhu,* Yuanchao Li. Rhodium-Catalyzed Redox-Neutral C-H Functionalization of Arylamine N-Oxides with Diazo Compounds: Primary C(sp3)-H/C(sp2)-H Activation and Oxygen Atom Transfer. Angew. Chem. Int. Ed. 2015, 54, 12121-12126.
11.Yaxi Yang, Rukang Zhang, Zhaojun Li, Lianghe Mei, Shili Wan, Hong Ding, Zhifeng Chen, Jing Xing, Huijin Feng, Jie Han, Hualiang Jiang, Mingyue Zheng,*Cheng Luo,* Bing Zhou.*Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors. J. Med. Chem. 2020, 63, 1337.
12.Zizhou Li, Senhao Xiao, Yaxi Yang, Chao Chen, Tian Lu, Zhifeng Chen, Hualiang Jiang, Shijie Chen, Cheng Luo,* and Bing Zhou.* Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-terminal (BET) Bromodomain Inhibitors. J. Med. Chem., 2020, 63, 8, 3956-3975
